Drug and neurofilament levels in serum and breastmilk of women with multiple sclerosis exposed to natalizumab during pregnancy and lactation

HIGHLIGHTS

  • who: Undine Proschmann from the University Medical Center Hamburg-Eppendorf, Germany have published the paper: Drug and Neurofilament Levels in Serum and Breastmilk of Women With Multiple Sclerosis Exposed to Natalizumab During Pregnancy and Lactation, in the Journal: (JOURNAL)
  • what: The authors observed very low transfer of NAT into breastmilk similar to previous reports .
  • future: Studies are needed to investigate the impact of parturition per se and subclinical MS disease activity on maternal neuronal integrity. not be clinically significant and measurement of serum concentration across pregnancy seems not to be required.
 

Logo ScioWire Beta black

If you want to have access to all the content you need to log in!

Thanks :)

If you don't have an account, you can create one here.

 

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?